Page last updated: 2024-08-17

levodopa and fce 23884

levodopa has been researched along with fce 23884 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buonamici, M; Cervini, MA; Maj, R; Mantegani, S; Rossi, AC1
Blanchet, PJ; Chase, TN; de Jong, D; Metman, LV; Mouradian, MM1

Trials

1 trial(s) available for levodopa and fce 23884

ArticleYear
Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:3

    Topics: Aged; Antiparkinson Agents; Carbidopa; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2; Treatment Outcome

1996

Other Studies

1 other study(ies) available for levodopa and fce 23884

ArticleYear
A new dopamine agonist in dopamine deprived systems: FCE 23884.
    Neurochemistry international, 1992, Volume: 20 Suppl

    Topics: Animals; Apomorphine; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Levodopa; Male; Mice; Motor Activity; Reserpine; Time Factors

1992